Outcomes Assessment in End - Stage Kidney Disease - Measurements and Applications in Clinical Practice

Indexed in: Book Citation Index, Science Edition, EBSCO.

With an increase of the population of elderly people in modern society due to advances in medicine and healthcare facilities, there is also an increase in the incidence and duration of chronic ...
[view complete introduction]

US $
15

*(Excluding Mailing and Handling)



Quality of Life Assessment in Kidney Transplantation

Pp. 80-90 (11)

Pavlos Malindretos, Stamatina Zili and Pantelis Sarafidis

Abstract

Transplanted patients generally experience lower health related quality of life (HRQoL) compared to general population. The vast majority of studies evaluating quality of life of patients before and after renal transplantation are in favour of transplanted patients. Immunosuppressive treatment side effects seem to have a negative impact on patients’ HRQoL. Nevertheless, HRQoL is generally significantly improved in children, adolescents and adults alike. Further more, living kidney transplant donors seem to present better HRQoL and improved depression status after a successful kidney transplantation. Even when older living donors are carefully selected, there is no need to be excluded from transplantation screening programs. Kidney transplantation represents the only known definite treatment of end - stage kidney disease (ESKD). When carefully planned and performed it will lead to both improved survival and health related quality of life of patients with advanced chronic kidney disease.

Keywords:

Health related quality of life, HRQoL, quality of life, QoL, transplantation, kidney transplantation, children, adolescents, adults.

Affiliation:

Department of Nephrology, Peritoneal Dialysis Section, Achillopouleion General Hospital, Volos, Greece.